Pyxis Oncology Quote - PYXS

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.5407

Bid

1.54

Offer

1.64

Volume

949,929

1.53 Day's Range 1.6215

1.49 52 Week Range 6.85

Market Cap

91.619M

Previous Close

1.59

Open

1.59

Last Trade

1.54

Last Trade Time

Financial Volume

US$ 1,479,617

VWAP

1.5576

Average Volume (3m)

1,294,014

Shares Outstanding

59,465,729

Dividend Yield

PE Ratio

-1.25

Earnings Per Share (EPS)

-1.24

Revenue

Net Profit

-73.79M

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

pyxisoncology.com

Headquarters

Wilmington, Delaware, USA

Founded

Pyxis Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PYXS. The last closing price for Pyxis Oncology was US$1.59. Over the last year, Pyxis Oncology shares have traded in a share price range of US$ 1.49 to US$ 6.85.

Pyxis Oncology currently has 59,465,729 shares in issue. The market capitalisation of Pyxis Oncology is US$94.55 million. Pyxis Oncology has a price to earnings ratio (PE ratio) of -1.25.

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0693	-4.30434782609	1.61	1.69	1.54	668909	1.62118033	CS
4	-0.4693	-23.3482587065	2.01	2.09	1.49	1154898	1.70462033	CS
12	-1.9593	-55.98	3.5	5.3899	1.49	1294014	2.54573627	CS
26	-1.7393	-53.0274390244	3.28	5.3899	1.49	856541	2.82654955	CS
52	-0.2493	-13.9273743017	1.79	6.85	1.49	783002	3.54018969	CS
156	-8.6693	-84.9098922625	10.21	11.5	1.1	663216	3.7018798	CS
260	-17.4593	-91.8910526316	19	19	1.1	635794	3.93280867	CS

PYXS - Frequently Asked Questions (FAQ)

What is the current Pyxis Oncology share price?

The current share price of Pyxis Oncology is US$ 1.5407

How many Pyxis Oncology shares are in issue?

Pyxis Oncology has 59,465,729 shares in issue

What is the market cap of Pyxis Oncology?

The market capitalisation of Pyxis Oncology is USD 94.55M

What is the 1 year trading range for Pyxis Oncology share price?

Pyxis Oncology has traded in the range of US$ 1.49 to US$ 6.85 during the past year

What is the PE ratio of Pyxis Oncology?

The price to earnings ratio of Pyxis Oncology is -1.25

What is the reporting currency for Pyxis Oncology?

Pyxis Oncology reports financial results in USD

What is the latest annual profit for Pyxis Oncology?

The latest annual profit of Pyxis Oncology is USD -73.79M

What is the registered address of Pyxis Oncology?

The registered address for Pyxis Oncology is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Pyxis Oncology website address?

The website address for Pyxis Oncology is pyxisoncology.com

Which industry sector does Pyxis Oncology operate in?

Pyxis Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WATTEnergous Corporation	US$ 2.70 (556.61%)	226.21M
NXUNXU Inc	US$ 1.52 (524.49%)	572.73M
HOLOMicroCloud Hologram Inc	US$ 6.40 (166.67%)	221.85M
INTZIntrusion Inc	US$ 5.67 (162.50%)	132.97M
SMXSMX Security Matters Public Company	US$ 0.803558 (127.25%)	370.63M
ICGIntchains Group Ltd	US$ 3.39 (-63.67%)	1.77M
ABPAbpro Holdings Inc	US$ 2.10 (-53.23%)	2.17M
LITMSnow Lake Resources Ltd	US$ 0.9212 (-42.43%)	69.28M
TRAWTraws Pharma Inc	US$ 8.33 (-37.93%)	1.2M
BDMDBaird Medical Investment Holdings Ltd	US$ 1.07 (-37.79%)	153.54k
NXUNXU Inc	US$ 1.52 (524.49%)	572.73M
SMXSMX Security Matters Public Company	US$ 0.803558 (127.25%)	370.63M
VINCVincerx Inc	US$ 0.3243 (67.16%)	335.59M
XTIAXTI Aerospace Inc	US$ 0.0395 (0.00%)	292.67M
WATTEnergous Corporation	US$ 2.70 (556.61%)	226.21M